The Role of Perioperative Heart Rate Variability in Predicting Rebound Pain After Total Knee Arthroplasty: A Prospective Observational Study

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study aims to investigate whether heart rate variability (HRV), a marker of autonomic nervous system activity, can predict the occurrence of rebound pain after total knee arthroplasty (TKA). Rebound pain is defined as a sudden and intense pain episode (NRS ≥7) that typically arises after the resolution of peripheral nerve blocks used for postoperative analgesia. Patients undergoing elective unilateral TKA under spinal anesthesia with peripheral nerve blocks will be included. HRV will be measured both before and after surgery using a chest-worn heart rate monitor. Pain levels, analgesic consumption, sleep quality, and patient satisfaction will also be recorded. The primary goal is to determine whether perioperative HRV values can serve as a predictive biomarker for rebound pain. Secondary outcomes include the relationship between HRV and pain intensity, opioid use, sleep quality, and length of hospital stay. The findings may contribute to developing individualized pain management strategies for TKA patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• Age between 18 and 70 years

• American Society of Anesthesiologists (ASA) physical status I-III

• Scheduled for elective, unilateral total knee arthroplasty under spinal anesthesia

• Planned use of multimodal analgesia including peripheral nerve blocks

• Ability to provide written informed consent

• Ability to understand and complete pain diaries and questionnaires

Locations
Other Locations
Turkey
Konya City Hospital
RECRUITING
Konya
Contact Information
Primary
Mahmut Tutar, MD
masatu42@gmail.com
+905552723704
Time Frame
Start Date: 2025-05-20
Estimated Completion Date: 2025-12-25
Participants
Target number of participants: 112
Sponsors
Leads: Konya City Hospital

This content was sourced from clinicaltrials.gov